Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway. - sprookjes - yvandenbroek - TriplyDB

Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

http://www.wikidata.org/entity/Q34544365

about

Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.Endothelial TWIST1 promotes pathological ocular angiogenesis.A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.Diabetic Macular Edema: From Old Concepts to New Therapeutic Avenues.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.Voluntary running exercise protects against sepsis-induced early inflammatory and pro-coagulant responses in aged mice.Alterations of retinal vasculature in cystathionine-β-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia Vascular endothelial growth factor (VEGF), mast cells and inflammation.Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.

P2860

Q34341837-E4B0FEF7-8169-44C4-9ECF-A78C290D2BAD Q35441276-A7455B7B-6D58-4EEC-BE1D-029487B3C992 Q35665701-9FCE5B9E-A6FC-4C44-B5CD-8717FDF395BB Q36178953-83243AE8-B260-4B48-81FC-65C601E7A2B6 Q36379513-2BB7451C-DD43-4FF9-90FB-C55D9499539E Q37577284-D48A9523-1585-493A-AA7B-EB28F3B6023D Q41319297-7F53AD9F-80E4-4FA5-A0AF-24F13F0A8715 Q42003476-44E0E8AE-9303-4838-BD98-D0D60F5934BE Q44817598-53A1EDAC-2346-43FB-A60D-8081D44311F8 Q53139818-86978DDE-B4AD-40ED-8847-8E660EDB6C33

P2860

Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

http://www.wikidata.org/entity/Q34544365

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@ast

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@en

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@nl

type

label

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@ast

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@en

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@nl

prefLabel

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@ast

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@en

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@nl

P1433

Q34544365-245D0DEB-FD26-49AB-A492-066625C26D46

P1476

Q34544365-4352C070-ED93-44CF-9762-37C0D368E318

P2093

Q34544365-0BDCF524-573D-48A7-BC66-DD76FE12BBD4

Q34544365-38FBF914-C44D-4478-A782-8DF48E2E6B5E

Q34544365-71A80158-8ABD-440E-AE98-AA35740EB9C1

Q34544365-906F44BB-3FE4-4868-A9C9-D8902FBE2B1C

Q34544365-F4BAD21A-431F-4A47-8BF3-DE10910322D4

Q34544365-F4F02BA5-68D7-4204-980E-624EBB43612F

P2860

Q34544365-01A83DBE-9BEA-42B2-A624-AB4262187A51

Q34544365-09CCF9FE-B2F7-4534-8B02-2B57BDE862F6

Q34544365-0C90DA40-56D7-4FEC-A0AD-CBA26FB79103

Q34544365-12CCC348-1E72-4693-B0CF-0407534D0225

Q34544365-180EC7E7-1CF1-4AC8-8181-D1F0FFFC392F

Q34544365-1E27D344-50D5-45EB-8E01-F07DCA209EB5

Q34544365-1FF12A60-1D53-4A16-90CA-31ED79233726

Q34544365-213BEE3F-9C10-45E9-86EB-2E25250AD7EC

Q34544365-2320BED0-7B6B-43A8-93FF-F55068BF60FF

Q34544365-275644C9-2AF1-4C68-BAAD-2055C3DC7515

P304

Q34544365-330A249A-A64F-45DF-BFE5-1A24ACF16D8C

P31

Q34544365-A1365342-B846-4586-8B8B-2267A2090480

P356

Q34544365-65D95BD4-FE29-4BFB-B77A-7719EFC689F2

P407

Q34544365-07BEDE7F-9792-4C1F-897B-878C628B3F83

P433

Q34544365-C3C40BA1-2BB7-47D1-A309-14734DEE9C0F

P478

Q34544365-8A0D31B2-4218-4466-86AB-3F85F9CC16D2

P577

Q34544365-4F651C1B-3E7D-408F-B153-4001094BA04B

P698

Q34544365-09034A08-2E94-4DD0-9A74-B17586327A05

P921

Q34544365-8BB3290A-7BCF-4306-A650-AA8559C001AA

P932

Q34544365-8B7BE553-CE7E-448C-B11D-1B8B4BC98CAB

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Hyperoxia causes regression of ...... egulating VEGF/VEGFR2 pathway.

@en

P2093

Hua Liu

http://www.w3.org/2001/XMLSchema#string

Robert W Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

Steven E Brooks

http://www.w3.org/2001/XMLSchema#string

Wenbo Zhang

http://www.w3.org/2001/XMLSchema#string

Zhimin Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro

Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity

Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy

Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia

Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen

Targeted deletion of Vegfa in adult mice induces vision loss

Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1)

Caspases: enemies within

P304

918-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.12-11291

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23307955

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3564450

http://www.w3.org/2001/XMLSchema#string